We are pleased to share the online publication of the conference report from the KDIGO Controversies Conference on the Relationship Between Obesity and CKD: Pathophysiology, Prognosis, and Management. Read the full report in @Kidney_Int: kdigo.co/Obesity-CKD-Confere… Read the news release: kdigo.co/Obesity-CKD-Confere… The conference brought together patients and international experts in nephrology, endocrinology, epidemiology, and nutrition to examine emerging evidence and define research priorities to address the increasing global burden of obesity-related CKD. The conference was co-chaired by Dr. Susan Furth (US), and @PeterRossing (DK). “Obesity is not simply a coexisting condition in CKD; it influences kidney function across the life course,” said Dr. Furth. “Because sustained exposure to obesity beginning early in life confers risks for CKD and cardiovascular disease, there is an important need for earlier identification, improved assessment tools, and prevention strategies. Patient participants at the conference emphasized the need for patient-centered, stigma-free care delivered by a multidisciplinary team.” “Effective obesity treatment has the potential to improve kidney outcomes far beyond weight reduction alone,” said Dr. Rossing. “As with metabolic and bariatric surgery, newer pharmacologic therapies, including GLP-1 receptor agonists, can lead to meaningful weight loss and promising cardiovascular and kidney benefits. At the same time, critical evidence gaps remain around optimal timing and duration of interventions, particularly across CKD stages. Addressing these gaps will be essential to translating innovation into better kidney care.” #obesity #CKD